Find clinical trials for Chronic Lymphocytic Leukemia in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Chronic Lymphocytic Leukemia trials near Cincinnati, OH, USA:
Multicenter Parallel 2 Cohort Phase 2 Study of LP-168 and Obinutuzumab for Previously Treated, and T474 Gatekeeper Mutant Chronic Lymphocytic...
Phase 2
Cincinnati, Ohio, United States
and preliminary efficacy of ZE50-0134 in relapsed and refractory chronic lymphocytic leukemia, small lymphocytic ...
Phase 1
Cincinnati, Ohio, United States and 3 other locations
This study will evaluate the long-term safety of pirtobrutinib in participants with previously treated chronic lymphocytic leukemia...
Phase 4
Cincinnati, Ohio, United States of America and 50 other locations
with pirtobrutinib in patients with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic...
Phase 3
Dayton, Ohio, United States and 16 other locations
The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing o...
Phase 2
Cincinnati, Ohio, United States of America and 74 other locations
rituximab in treating adults with relapsed and/or refractory (R/R) chronic lymphocytic leukemia/small lymphocytic...
Phase 3
Cincinnati, Ohio, United States and 63 other locations
The main purpose of Part 1 of this study is to assess the efficacy and safety of 3 dose levels of Pirtobrutinib in participants with chronic ...
Phase 2
Edgewood, Kentucky, United States and 135 other locations
Epcoritamab will be tested either inRelapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) as:* Monotherapy, or* Com...
Phase 1, Phase 2
Cincinnati, Ohio, United States and 86 other locations
The goal of this study is to evaluate nemtabrutinib compared with investigator's choice of ibrutinib or acalabrutinib in participants with chronic...
Phase 3
Edgewood, Kentucky, United States and 190 other locations
The purpose of this study is to compare the efficacy and safety of fixed duration pirtobruitinib (LOXO-305) with VR (Arm A) compared to VR alone (Arm...
Phase 3
Cincinnati, Ohio, United States of America and 179 other locations
Clinical trials
Research sites
Resources
Legal